IVERIC bio, Inc.

IVERIC bio, Inc. (NASDAQ: ISEE), relating to its proposed sale to Astellas Pharma Inc. Under the terms of the agreement, ISEE shareholders are expected to receive $40.00 in cash per share they own.

To receive more information regarding the investigation of IVERIC bio, Inc. please fill out the form below.